Search

for
Search:

Research

5 / 77 results

research Biological Profile of Cortexolone 17a-Propionate (CB-03-01), a New Topical and Peripherally Selective Androgen Antagonist

5 citations , December 2011 in “Drug Research”

CB-03-01 is a promising skin cream for treating hormone-related skin problems without causing harmful body-wide effects.

A Phase 1 Study to Investigate the Effects of Cortexolone 17α-Propionate, Also Known as Clascoterone, on the QT Interval Using the Meal Effect to Demonstrate ECG Assay Sensitivity

research A Phase 1 Study to Investigate the Effects of Cortexolone 17α‐Propionate, Also Known as Clascoterone, on the QT Interval Using the Meal Effect to Demonstrate ECG Assay Sensitivity

2 citations , May 2021 in “Clinical Pharmacology in Drug Development”

Clascoterone is safe for the heart, even at high doses.

research Cortexolone 17a-propionate: Preclinical profile of a new topical, skin selective, steroidal antiandrogen

April 2012 in “Journal of the American Academy of Dermatology”

Clofazimine may be effective for treating ashy dermatosis.

research Detection of urine metabolites in polycystic ovary syndrome by UPLC triple-TOF-MS

23 citations , June 2015 in “Clinica Chimica Acta”

Researchers found potential urine markers for polycystic ovary syndrome, including testosterone-glucuronide and 11α-hydroxyprogesterone, which may help diagnose the condition.

research Cortexolone 17α-Propionate (Clascoterone) is an Androgen Receptor Antagonist in Dermal Papilla Cells In Vitro

4 citations , February 2019 in “PubMed”

Clascoterone may be an effective topical treatment for hair loss.

View more "cortexolone metabolite" in research →

Community Join

5 / 1000+ results

community Clascoterone is the way to go if you cannot use DHT blockers

in Chat 11 upvotes 3 months ago

Clascoterone is suggested as an alternative for those who experience side effects from finasteride and dutasteride. It is not widely available yet, but some users are obtaining it from compounding pharmacies or suppliers like Echemi.

community Breezula will hit the market in 2026, Cosmo Pharmaceuticals statement!

in Product 50 upvotes 2 years ago

Breezula, a hair loss treatment, is expected to cost around $100 a month and is anticipated to be released in 2026. The effectiveness of Breezula is debated, with some suggesting it loses effectiveness over time and others arguing it maintains hair compared to baseline.

community PYRILUTAMIDE KX-826 experience

in Research/Science 100 upvotes 4 years ago

A user's experience with the hair loss treatment Pyrilutamide KX-826, which has resulted in some side effects and shedding. The conversation also includes advice for baseline pictures and trying treatments for at least 6 months.

community This could be it!!! New treatment increase hair 500%

in Research/Science 343 upvotes 8 months ago

Clascoterone (Breezula) shows a potential 500% increase in hair growth, possibly outperforming minoxidil and finasteride. It is in advanced trials, with hopes for FDA approval, but cost and side effects are concerns.

community Clinical Trial: Clascoterone (Cortexolone 17A-Propionate)

in Research/Science 24 upvotes 2 years ago

A user is joining a clinical trial for Clascoterone, a drug approved for acne but being tested for hair loss. They previously tried finasteride with limited success and plan to share updates on their experience with the new treatment.

View more "cortexolone metabolite" in community →

Learn

2 / 801 results

learn Overview

learn enoxolone

View more "cortexolone metabolite" in learn →

Clinics

2 / 2 results

Experts

— no results

Try a deeper search in experts →